trial

Magnetic Seizure Therapy for Psychotic Disorders

NCTId NCT06581302
as of 2026-07-01
at a glance
· Recruiting
Enrollment 50 (estimated)
Primary completion 2025-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-09-01
Primary completion
2025-12-30
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Sponsors

Investigators

1
Jijun Wang, M.D., Ph.DPrincipal Investigator

Sites

2 total
Shanghai, ChinaShanghai, China

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2025-12-30
Status
RECRUITING
relationships
The graph out of here